相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Isolating live cell clones from barcoded populations using CRISPRa-inducible reporters
Christian Umkehrer et al.
NATURE BIOTECHNOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression
Cuicui Liu et al.
CANCER RESEARCH (2021)
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade
Kartik Sehgal et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells
Giulia De Conti et al.
CANCERS (2021)
Cycling cancer persister cells arise from lineages with distinct programs
Yaara Oren et al.
NATURE (2021)
Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer
Heidie Frisco Cabanos et al.
CANCERS (2021)
Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma Agent
Saketh S. Dinavahi et al.
MOLECULAR CANCER THERAPEUTICS (2020)
ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer
Ryuhei Kawakami et al.
CANCER SCIENCE (2020)
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer
Rocio Rebollido-Rios et al.
ONCOGENE (2020)
Targeting Tumor Microenvironment by Small-Molecule Inhibitors
Shangwei Zhong et al.
TRANSLATIONAL ONCOLOGY (2020)
Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
Helene Gregoire et al.
FRONTIERS IN PHARMACOLOGY (2020)
Stemming the tide of drug resistance in cancer
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2020)
Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
Anmi Jose et al.
CANCERS (2020)
Mechanisms of Cancer Resistance to Immunotherapy
Rilan Bai et al.
FRONTIERS IN ONCOLOGY (2020)
Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells
Valenti Gomez et al.
SCIENCE SIGNALING (2020)
Stemness Related Genes Revealed by Network Analysis Associated With Tumor Immune Microenvironment and the Clinical Outcome in Lung Adenocarcinoma
Hao Zeng et al.
FRONTIERS IN GENETICS (2020)
Gene Panel of Persister Cells as a Prognostic Indicator for Tumor Repopulation After Radiation
Yucui Zhao et al.
FRONTIERS IN ONCOLOGY (2020)
Insight Into Nanoliposomes as Smart Nanocarriers for Greening the Twenty-First Century Biomedical Settings
K. M. Aguilar-Perez et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation
Shensi Shen et al.
CELL REPORTS (2020)
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness?
Beatrice Aramini et al.
FRONTIERS IN MEDICINE (2020)
Medulloblastoma: Onset of the molecular era
Pavan Kumar Dhanyamraju et al.
MOLECULAR BIOLOGY REPORTS (2020)
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer
Dinoop Ravindran Menon et al.
THERANOSTICS (2020)
Single-cell lineage analysis reveals genetic and epigenetic interplay in glioblastoma drug resistance
Christine E. Eyler et al.
GENOME BIOLOGY (2020)
CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition
Cynthia M. Simbulan-Rosenthal et al.
JOURNAL OF ONCOLOGY (2019)
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
Maria Laura De Angelis et al.
FRONTIERS IN ONCOLOGY (2019)
Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells
Shinkichi Morita et al.
CANCER LETTERS (2019)
Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer
Francois M. Vallette et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Targeting Cancer Cell Dormancy
Ariadna Recasens et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
Giuseppe Vassalli
STEM CELLS INTERNATIONAL (2019)
Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells
Ruiqi Lu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
A highlight on Sonic hedgehog pathway
Gabriela Basile Carballo et al.
CELL COMMUNICATION AND SIGNALING (2018)
Role of Macrophages in Brain Tumor Growth and Progression
Elia Guadagno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
CD133-targeted delivery of self-assembled PEGylated carboxymethylcellulose-SN38 nanoparticles to colorectal cancer
Mona Alibolandi et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Lan Thi Hanh Phi et al.
STEM CELLS INTERNATIONAL (2018)
Rethinking Extended Adjuvant Antiestrogen Therapy to Increase Survivorship in Breast Cancer
Balkees Abderrahman et al.
JAMA ONCOLOGY (2018)
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
Tyler Risom et al.
NATURE COMMUNICATIONS (2018)
ALDH1 Bio-activates Nifuroxazide to Eradicate ALDHHigh Melanoma-Initiating Cells
Sana Sarvi et al.
CELL CHEMICAL BIOLOGY (2018)
The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation
Ann-Sofie B. Brier et al.
NUCLEIC ACIDS RESEARCH (2017)
High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma
Laura A. Taylor et al.
MODERN PATHOLOGY (2017)
DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties
Joana Soares et al.
MOLECULAR ONCOLOGY (2017)
Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments
Georg Fluegen et al.
NATURE CELL BIOLOGY (2017)
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Elodie M. Kuntz et al.
NATURE MEDICINE (2017)
Marked for death: targeting epigenetic changes in cancer
Sophia Xiao Pfister et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
H3K4 demethylase KDM5B regulates global dynamics of transcription elongation and alternative splicing in embryonic stem cells
Runsheng He et al.
NUCLEIC ACIDS RESEARCH (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge et al.
CANCER DISCOVERY (2017)
Distinct histone modifications denote early stress-induced drug tolerance in cancer
Abdullah Al Emran et al.
Oncotarget (2017)
Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
Jorg U. Schmohl et al.
CANCER RESEARCH AND TREATMENT (2017)
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure
Gulfem Dilek Guler et al.
CANCER CELL (2017)
The diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of patients with brain tumor
Wojciech Jelski et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment
Tao Wang et al.
CANCER BIOLOGY & THERAPY (2016)
Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment
Minmin Li et al.
MOLECULAR MEDICINE REPORTS (2016)
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova et al.
NATURE CHEMICAL BIOLOGY (2016)
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata et al.
NATURE MEDICINE (2016)
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
Michael Ramirez et al.
NATURE COMMUNICATIONS (2016)
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Hiroyuki Tomita et al.
ONCOTARGET (2016)
CD271 regulates the proliferation and motility of hypopharyngeal cancer cells
Mai Mochizuki et al.
SCIENTIFIC REPORTS (2016)
Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts
Michael Ngo et al.
CELL REPORTS (2016)
Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator
Xiang Zhou et al.
ELIFE (2016)
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
Seyedmehdi Shojaee et al.
CANCER CELL (2015)
CD133+ melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: Significance for melanoma treatment
Abdelouahid El-Khattouti et al.
CANCER LETTERS (2015)
The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracilresistance in human colon cancer cells
Naruji Kugimiya et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
Lei Zhao et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
Hyo-eun C. Bhang et al.
NATURE MEDICINE (2015)
A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
Hovav Nechushtan et al.
ONCOLOGIST (2015)
Nerve Growth Factor and proNGF Simultaneously Promote Symmetric Self-Renewal, Quiescence, and Epithelial to Mesenchymal Transition to Enlarge the Breast Cancer Stem Cell Compartment
Elisa Tomellini et al.
STEM CELLS (2015)
ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma
Kaori Tanaka et al.
ONCOTARGET (2015)
A stress-induced early innate response causes multidrug tolerance in melanoma
D. Ravindran Menon et al.
ONCOGENE (2015)
Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity
Sulan Li et al.
ONCOLOGY REPORTS (2015)
Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
Yifang Wei et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis
J. Yan et al.
BRITISH JOURNAL OF CANCER (2014)
JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer
Shoji Yamamoto et al.
CANCER CELL (2014)
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
Debasish Raha et al.
CANCER RESEARCH (2014)
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale et al.
NATURE (2014)
SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
R. Santini et al.
ONCOGENE (2014)
CD271+ Osteosarcoma Cells Display Stem-Like Properties
Jiguang Tian et al.
PLOS ONE (2014)
Identification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype
Hitomi Ohmura-Kakutani et al.
PLOS ONE (2014)
CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma
Oihana Murillo-Sauca et al.
ONCOTARGET (2014)
Lentiviral and targeted cellular barcoding reveals ongoing clonal dynamics of cell lines in vitro and in vivo
Shaina N. Porter et al.
GENOME BIOLOGY (2014)
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer
Muhammad Alamgeer et al.
BREAST CANCER RESEARCH (2014)
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
Radoslaw Januchowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
RNA aptamers targeting cancer stem cell marker CD133
Sarah Shigdar et al.
CANCER LETTERS (2013)
Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma
Takahiro Kiyosue et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma
Kefeng Wang et al.
MEDICAL ONCOLOGY (2013)
Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment
Olivier Nolan-Stevaux et al.
PLOS ONE (2013)
CD271 Defines a Stem Cell-Like Population in Hypopharyngeal Cancer
Takayuki Imai et al.
PLOS ONE (2013)
TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition
Jin Koo Kim et al.
NEOPLASIA (2013)
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
Alysha K. Croker et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
Massimo Zollo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity
Gong Zhang et al.
MOLECULAR MEDICINE REPORTS (2012)
Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer
Yuta Wakamatsu et al.
PATHOLOGY INTERNATIONAL (2012)
RNA-Seq of Human Breast Ductal Carcinoma In Situ Models Reveals Aldehyde Dehydrogenase Isoform 5A1 as a Novel Potential Target
Hitchintan Kaur et al.
PLOS ONE (2012)
ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
Yuchun Luo et al.
STEM CELLS (2012)
Dynamics of targeted cancer therapy
Ivana Bozic et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application
Vindhya Koppaka et al.
PHARMACOLOGICAL REVIEWS (2012)
Targeted Inhibition of CD133+ Cells in Oral Cancer Cell Lines
M. Damek-Poprawa et al.
JOURNAL OF DENTAL RESEARCH (2011)
Dysregulated pH: a perfect storm for cancer progression
Bradley A. Webb et al.
NATURE REVIEWS CANCER (2011)
Isolation of tumorigenic circulating melanoma cells
Jie Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Mantle cell lymphoma activation enhances bortezomib sensitivity
Sarah K. Brennan et al.
BLOOD (2010)
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
A. Lugli et al.
BRITISH JOURNAL OF CANCER (2010)
High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
Christel van den Hoogen et al.
CANCER RESEARCH (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Perivascular Nitric Oxide Activates Notch Signaling and Promotes Stem-like Character in PDGF-Induced Glioma Cells
Nikki Charles et al.
CELL STEM CELL (2010)
Overexpression of p75NTR increases survival of breast cancer cells through p21waf1
Stephanie Verbeke et al.
CELLULAR SIGNALLING (2010)
Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma
Shilpa Lingala et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
SINGLE-MARKER IDENTIFICATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA CANCER STEM CELLS WITH ALDEHYDE DEHYDROGENASE
Matthew R. Clay et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Identification of a novel monoclonal antibody recognizing CD133
Suresh Kumar Swaminathan et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Selection of Tumorigenic Melanoma Cells Using ALDH
Jim B. Boonyaratanakornkit et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
Zeshaan A. Rasheed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Targeting leukemic stem cells by breaking their dormancy
Marieke Alida Gertruda Essers et al.
MOLECULAR ONCOLOGY (2010)
Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
Shan Deng et al.
PLOS ONE (2010)
Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma
Lina Prasmickaite et al.
PLOS ONE (2010)
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
Koji Morimoto et al.
CANCER SCIENCE (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes
Dan Ran et al.
EXPERIMENTAL HEMATOLOGY (2009)
p75NTR-dependent modulation of cellular handling of reactive oxygen species
Zhiping Mi et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Epigenetics in cancer: Targeting chromatin modifications
Leigh Ellis et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cancer stem cells: implications for the progression and treatment of metastatic disease
A. K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations
Stephanie Ma et al.
MOLECULAR CANCER RESEARCH (2008)
Identification of cells initiating human melanomas
Tobias Schatton et al.
NATURE (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide
Jan S. Moreb et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma
Tomoyuki Okumura et al.
CLINICAL CANCER RESEARCH (2006)
Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma
S. Tsunoda et al.
BRITISH JOURNAL OF CANCER (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
分享论文
